Literature DB >> 7682739

Delivery of whole liver-equivalent hepatocyte mass using polymer devices and hepatotrophic stimulation.

S Uyama1, P M Kaufmann, T Takeda, J P Vacanti.   

Abstract

Using hepatocytes injected into prevascularized polymer sponge devices, we studied hepatocyte survival and function after delivery of a whole liver-equivalent of cells into rats. LEW rats and enzyme-deficient Gunn rats served as recipients, respectively. Totally, 28.5 cm2 (0.5-cm thick) of polyvinyl alcohol sponges were implanted per animal. Hepatotrophic stimulation was induced by portacaval shunt and partial (70% or 30%) hepatectomy. Recipient rats received 5 x 10(8) hepatocytes (equivalent to whole rat liver) which were harvested from LEW and Wistar donors, respectively. After engraftment, histologic examination revealed hepatocyte remodeling in the device with capillaries lining plates of hepatocytes, and also tubular structures resembling early biliary radicles. BrdU staining revealed DNA synthesis in hepatocytes, providing evidence of regeneration within the grafts. Quantification of viable hepatocyte area at various time points was performed using computer-assisted morphometry. We then estimated a range of cell numbers from the quantitated cell area. The number of hepatocytes viable at day 7 was estimated at 27.5-46.0% and 6.6-11.0% in the mesentery and subcutaneous site, respectively. Thus the average number was estimated between 10.8% and 18.0% of initially injected hepatocytes. In the Gunn rat experiment, experimental rats that received normal Wistar hepatocytes showed a significantly greater decrease in total serum bilirubin compared with the concurrent control Gunn rats (P < 0.01). At week 1, serum bilirubin in experimental rats decreased to 74.7% (6.80 +/- 0.46 mg/dl) of pretransplantation level (9.10 +/- 0.47 mg/dl) and this was 71.4% of the control rats' bilirubin level (9.53 +/- 0.37 mg/dl). In conclusion, a hepatocyte mass equivalent to a whole rat liver can be delivered into prevascularized polymer sponge devices. At day 7 between 10.8% and 18.0% of these hepatocytes were estimated to be engrafted and functioning. Further optimization of this technique is necessary before clinical application is considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682739     DOI: 10.1097/00007890-199304000-00044

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

Review 3.  Isolated hepatocytes: use in experimental and clinical hepatology.

Authors:  A J Strain
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 4.  Engineered liver for transplantation.

Authors:  Basak E Uygun; Martin L Yarmush
Journal:  Curr Opin Biotechnol       Date:  2013-06-20       Impact factor: 9.740

Review 5.  Application of whole-organ tissue engineering in hepatology.

Authors:  Basak E Uygun; Martin L Yarmush; Korkut Uygun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-14       Impact factor: 46.802

Review 6.  Development of hepatic tissue engineering.

Authors:  Henning Cornelius Fiegel; Ulrich Kneser; Dietrich Kluth; Roman Metzger; Holger Till; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

7.  A stereotypic, transplantable liver tissue-culture system.

Authors:  B A Naughton; B Sibanda; J P Weintraub; J San Román; V Kamali
Journal:  Appl Biochem Biotechnol       Date:  1995 Jul-Sep       Impact factor: 2.926

Review 8.  Fetal and adult liver stem cells for liver regeneration and tissue engineering.

Authors:  H C Fiegel; Claudia Lange; U Kneser; W Lambrecht; A R Zander; X Rogiers; D Kluth
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

9.  Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat.

Authors:  H C Fiegel; G Pryymachuk; S Rath; O Bleiziffer; J P Beier; H Bruns; D Kluth; R Metzger; R E Horch; H Till; U Kneser
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.